Fonar - 44 Year Stock Price History | FONR
Historical daily share price chart and data for Fonar since 1981 adjusted for splits and dividends. The latest closing stock price for Fonar as of March 31, 2025 is 14.01.
- The all-time high Fonar stock closing price was 304.56 on December 07, 1982.
- The Fonar 52-week high stock price is 20.34, which is 45.2% above the current share price.
- The Fonar 52-week low stock price is 13.27, which is 5.3% below the current share price.
- The average Fonar stock price for the last 52 weeks is 15.97.
| Fonar Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 14.9190 | 15.1000 | 16.4100 | 13.2700 | 14.0100 | -7.46% |
| 2024 | 17.4810 | 20.1000 | 23.2400 | 14.3900 | 15.1400 | -22.60% |
| 2023 | 16.7782 | 16.8500 | 20.5000 | 12.5200 | 19.5600 | 16.78% |
| 2022 | 16.2372 | 15.0500 | 19.1000 | 13.3100 | 16.7500 | 14.88% |
| 2021 | 17.4325 | 18.3200 | 20.3500 | 14.5500 | 14.5800 | -16.01% |
| 2020 | 20.6611 | 20.1900 | 26.4900 | 11.2100 | 17.3600 | -11.83% |
| 2019 | 21.2884 | 21.2500 | 25.0700 | 19.2000 | 19.6900 | -2.72% |
| 2018 | 25.3970 | 24.3500 | 29.8000 | 20.0700 | 20.2400 | -16.88% |
| 2017 | 24.4442 | 19.2250 | 33.6000 | 17.4500 | 24.3500 | 27.15% |
| 2016 | 18.1649 | 16.7800 | 23.7800 | 13.3200 | 19.1500 | 10.95% |
| 2015 | 12.5383 | 10.2600 | 18.3300 | 9.1300 | 17.2600 | 65.96% |
| 2014 | 14.4175 | 20.1700 | 25.8800 | 9.6700 | 10.4000 | -50.96% |
| 2013 | 8.0377 | 4.6000 | 21.2080 | 4.5900 | 21.2080 | 389.79% |
| 2012 | 3.6961 | 1.7300 | 6.4000 | 1.6900 | 4.3300 | 154.11% |
| 2011 | 1.8012 | 1.3000 | 2.6500 | 1.2600 | 1.7040 | 31.08% |
| 2010 | 1.4941 | 1.7000 | 2.7200 | 1.0200 | 1.3000 | -17.20% |
| 2009 | 1.6153 | 0.9200 | 3.1900 | 0.6305 | 1.5700 | 89.16% |
| 2008 | 2.4096 | 5.3200 | 5.3200 | 0.6651 | 0.8300 | -84.04% |
| 2007 | 6.4535 | 7.4625 | 8.1400 | 4.2080 | 5.2000 | -26.14% |
| 2006 | 12.2480 | 17.7500 | 20.5000 | 6.3575 | 7.0400 | -58.59% |
| 2005 | 29.9601 | 39.2500 | 43.0000 | 17.0000 | 17.0000 | -56.69% |
| 2004 | 32.0002 | 29.0000 | 42.7500 | 25.5000 | 39.2500 | 36.52% |
| 2003 | 30.8156 | 26.7500 | 49.5000 | 20.2500 | 28.7500 | 7.48% |
| 2002 | 30.6672 | 30.5000 | 50.2500 | 24.2500 | 26.7500 | -10.08% |
| 2001 | 37.9889 | 32.8125 | 62.2500 | 25.7800 | 29.7500 | -9.33% |
| 2000 | 58.0171 | 46.8750 | 112.5000 | 28.1250 | 32.8125 | -22.22% |
| 1999 | 31.3335 | 35.1469 | 75.0000 | 18.7500 | 42.1875 | 35.03% |
| 1998 | 51.3194 | 69.6395 | 75.0547 | 26.5500 | 31.2428 | -57.05% |
| 1997 | 70.6273 | 55.7116 | 98.2703 | 53.3891 | 72.7346 | 25.33% |
| 1996 | 60.9817 | 65.7694 | 75.0547 | 52.6165 | 58.0342 | -11.76% |
| 1995 | 67.4010 | 47.1989 | 99.0429 | 41.0087 | 65.7694 | 32.81% |
| 1994 | 42.9459 | 53.3891 | 63.4493 | 30.9509 | 49.5214 | -7.24% |
| 1993 | 44.1630 | 44.1038 | 86.6625 | 28.6283 | 53.3891 | 32.69% |
| 1992 | 36.1328 | 30.9509 | 49.5214 | 27.8558 | 40.2362 | 30.00% |
| 1991 | 26.8857 | 13.1479 | 64.9969 | 10.8452 | 30.9509 | 122.02% |
| 1990 | 14.4265 | 16.2430 | 17.0354 | 13.1479 | 13.9403 | 6.03% |
| 1989 | 19.8094 | 27.8558 | 34.0460 | 8.5177 | 13.1479 | -57.52% |
| 1988 | 42.7807 | 46.4263 | 52.6165 | 24.7607 | 30.9509 | -23.08% |
| 1987 | 101.6388 | 131.2320 | 160.9450 | 37.1411 | 40.2362 | -68.75% |
| 1986 | 164.4092 | 146.0880 | 232.7510 | 121.3270 | 128.7560 | -11.86% |
| 1985 | 87.6510 | 89.1386 | 155.9920 | 59.4257 | 146.0880 | 73.53% |
| 1984 | 92.8086 | 111.4230 | 131.2320 | 56.9496 | 84.1864 | -20.93% |
| 1983 | 183.7186 | 245.1310 | 259.9870 | 103.9950 | 106.4710 | -56.57% |
| 1982 | 135.7044 | 212.9420 | 304.5570 | 69.3300 | 245.1310 | 13.79% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.087B | $0.103B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
| Boston Scientific (BSX) | United States | $149.209B | 40.19 |
| Stryker (SYK) | United States | $142.084B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
| Medtronic (MDT) | Ireland | $115.249B | 16.83 |
| Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
| Agilent Technologies (A) | United States | $33.351B | 22.03 |
| ResMed (RMD) | United States | $32.876B | 25.32 |
| Terumo (TRUMY) | Japan | $27.805B | 39.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
| Insulet (PODD) | United States | $18.442B | 78.86 |
| Baxter (BAX) | United States | $17.557B | 12.63 |
| Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
| Demant (WILYY) | Denmark | $8.048B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
| Lantheus Holdings (LNTH) | United States | $6.684B | 16.43 |
| Prestige Consumer Healthcare (PBH) | United States | $4.259B | 20.32 |
| Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.405B | 29.11 |
| Haemonetics (HAE) | United States | $3.193B | 15.02 |
| Envista Holdings (NVST) | United States | $2.972B | 23.64 |
| QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
| GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
| LeMaitre Vascular (LMAT) | United States | $1.893B | 43.25 |
| Neogen (NEOG) | United States | $1.881B | 21.67 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
| Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
| InMode (INMD) | Israel | $1.234B | 10.31 |
| Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
| BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
| Evolus (EOLS) | United States | $0.765B | 0.00 |
| Owens & Minor (OMI) | United States | $0.698B | 5.94 |
| CeriBell (CBLL) | United States | $0.689B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
| Valneva SE (VALN) | France | $0.545B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.436B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
| SNDL (SNDL) | Canada | $0.371B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| ZimVie (ZIMV) | United States | $0.301B | 18.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Quanterix (QTRX) | United States | $0.252B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
| Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Brainsway (BWAY) | Israel | $0.178B | 55.71 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| High Tide (HITI) | Canada | $0.153B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.116B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 24.44 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| Exagen (XGN) | United States | $0.064B | 0.00 |
| InterCure (INCR) | Israel | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 12.66 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
| Safety Shot (SHOT) | United States | $0.027B | 0.00 |
| INLIF (INLF) | $0.021B | 0.00 | |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |